Boris Decourt

1.4k total citations
48 papers, 1.0k citations indexed

About

Boris Decourt is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Boris Decourt has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 12 papers in Molecular Biology and 12 papers in Pharmacology. Recurrent topics in Boris Decourt's work include Alzheimer's disease research and treatments (27 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Dementia and Cognitive Impairment Research (10 papers). Boris Decourt is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Dementia and Cognitive Impairment Research (10 papers). Boris Decourt collaborates with scholars based in United States, France and Qatar. Boris Decourt's co-authors include Marwan N. Sabbagh, Debomoy K. Lahiri, Marwan N. Sabbagh, Daniel M. Suter, Jiong Shi, Yazan Al-Hasan, Aih Cheun Lee, Zoltán Mari, Aaron Walker and Aziz Hafidi and has published in prestigious journals such as Nature Medicine, Hepatology and Molecular Biology of the Cell.

In The Last Decade

Boris Decourt

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Decourt United States 17 487 323 231 183 126 48 1.0k
David Beaulieu‐Abdelahad United States 19 424 0.9× 408 1.3× 213 0.9× 205 1.1× 173 1.4× 31 1.0k
Sun-Ho Han South Korea 14 630 1.3× 400 1.2× 259 1.1× 119 0.7× 85 0.7× 17 1.0k
Mar Pacheco‐Herrero Dominican Republic 15 430 0.9× 322 1.0× 204 0.9× 122 0.7× 113 0.9× 23 967
Laia Montoliu‐Gaya Sweden 19 743 1.5× 347 1.1× 260 1.1× 147 0.8× 122 1.0× 49 1.2k
Anna Mietelska‐Porowska Poland 12 525 1.1× 334 1.0× 206 0.9× 100 0.5× 194 1.5× 16 1.0k
Darrell Sawmiller United States 19 512 1.1× 435 1.3× 131 0.6× 180 1.0× 171 1.4× 53 1.2k
Katherine R. Sadleir United States 12 850 1.7× 488 1.5× 255 1.1× 256 1.4× 234 1.9× 21 1.3k
Keenan Sterling China 4 420 0.9× 322 1.0× 158 0.7× 173 0.9× 156 1.2× 5 925
Teemu Natunen Finland 18 481 1.0× 453 1.4× 215 0.9× 112 0.6× 168 1.3× 44 1.1k

Countries citing papers authored by Boris Decourt

Since Specialization
Citations

This map shows the geographic impact of Boris Decourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Decourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Decourt more than expected).

Fields of papers citing papers by Boris Decourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Decourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Decourt. The network helps show where Boris Decourt may publish in the future.

Co-authorship network of co-authors of Boris Decourt

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Decourt. A scholar is included among the top collaborators of Boris Decourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Decourt. Boris Decourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boles, Annette, John Culberson, Jonathan Singer, et al.. (2026). Relationships between diabetes, vitamin D status, depression, and Hispanic ethnicity: a project FRONTIER study. Nutrition and Diabetes. 16(1). 1–1.
2.
Sabbagh, Marwan N., et al.. (2025). Alzheimer’s disease: Clinical trials to watch. Med. 6(8). 100771–100771.
3.
Singer, Jonathan, et al.. (2025). The role of inflammation, chronic pain, and hypertension on cognitive functioning in an underserved, rural population: a Project FRONTIER study. Journal of Clinical and Experimental Neuropsychology. 47(4). 249–262. 1 indexed citations
4.
Decourt, Boris, et al.. (2025). Informant-Based Questionnaires in the Diagnostic Pathway for Screening of Cognitive Impairment. Neurology and Therapy. 15(1). 29–40.
5.
Decourt, Boris, et al.. (2024). Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease. Biomedicines. 12(1). 99–99. 15 indexed citations
6.
Decourt, Boris, et al.. (2024). Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years. Neurology and Therapy. 13(6). 1571–1595. 8 indexed citations
7.
Decourt, Boris, et al.. (2024). Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications. Neurology and Therapy. 13(6). 1541–1557. 4 indexed citations
8.
Morris, Claudia R., Jonathan Kopel, John Culberson, et al.. (2024). Relationships between Diabetes, Vitamin D Status, Neuropsychological Functioning, and Hispanic Ethnicity in Older Rural West Texans: A Project FRONTIER Study. Alzheimer s & Dementia. 20(S2). 1 indexed citations
9.
Decourt, Boris, et al.. (2024). Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review. Neurology and Therapy. 13(4). 975–1013. 3 indexed citations
10.
Decourt, Boris, et al.. (2023). Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 95(4). 1573–1584. 4 indexed citations
11.
Sabbagh, Marwan N., Justin Miller, Stephen E. Jones, et al.. (2021). Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer’s Disease?. Journal of Alzheimer s Disease Reports. 5(1). 207–211. 7 indexed citations
12.
13.
Decourt, Boris, Debomoy K. Lahiri, & Marwan N. Sabbagh. (2016). Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease. Current Alzheimer Research. 14(4). 412–425. 285 indexed citations
14.
Ren, Yuan, Bingbing Wu, Boris Decourt, et al.. (2015). Src and cortactin promote lamellipodia protrusion and filopodia formation and stability in growth cones. Molecular Biology of the Cell. 26(18). 3229–3244. 38 indexed citations
15.
Decourt, Boris, Thomas G. Beach, Michael Malek‐Ahmadi, et al.. (2013). BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem Brains. Current Alzheimer Research. 10(3). 309–315. 9 indexed citations
16.
Decourt, Boris. (2013). Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer\'s Related Pathological Changes in Down Syndrome. Journal of Alzheimer’s Disease & Parkinsonism. s7. 2–2. 10 indexed citations
17.
Gonzales, Amanda M., Ashley L. Siniard, Aaron Walker, et al.. (2013). A cellular model of amyloid precursor protein processing and amyloid-β peptide production. Journal of Neuroscience Methods. 223. 114–122. 18 indexed citations
18.
Decourt, Boris, Aaron Walker, Michael Malek‐Ahmadi, et al.. (2012). Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets. 24(3). 235–238. 14 indexed citations
19.
Decourt, Boris, Yohan Bouleau, Didier Dulon, & Aziz Hafidi. (2005). Expression analysis of neuroleukin, calmodulin, cortactin, and Rho7/Rnd2 in the intact and injured mouse brain. Developmental Brain Research. 159(1). 36–54. 20 indexed citations
20.
Decourt, Boris, Yohan Bouleau, Didier Dulon, & Aziz Hafidi. (2005). Identification of differentially expressed genes in the developing mouse inferior colliculus. Developmental Brain Research. 159(1). 29–35. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Beaulieu‐Abdelahad Breakdown of academic impact, for papers by Sun-Ho Han Breakdown of academic impact, for papers by Mar Pacheco‐Herrero Breakdown of academic impact, for papers by Laia Montoliu‐Gaya Breakdown of academic impact, for papers by Anna Mietelska‐Porowska Breakdown of academic impact, for papers by Darrell Sawmiller Breakdown of academic impact, for papers by Katherine R. Sadleir Breakdown of academic impact, for papers by Keenan Sterling Breakdown of academic impact, for papers by Teemu Natunen
Rankless by CCL
2026